Dutasteride (Actavis Pharma, Inc.)
Welcome to the PulseAid listing for the Dutasteride drug offered from Actavis Pharma, Inc.. This 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Actavis Pharma, Inc. |
| NON-PROPRIETARY NAME: | Dutasteride |
| SUBSTANCE NAME: | DUTASTERIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | 5-alpha Reductase Inhibitor [EPC],5-alpha Reductase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-11-20 |
| END MARKETING DATE: | 0000-00-00 |
Dutasteride HUMAN PRESCRIPTION DRUG Details:
| Item Description | Dutasteride from Actavis Pharma, Inc. |
| LABELER NAME: | Actavis Pharma, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/1) |
| START MARKETING DATE: | 2015-11-20 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-2292_35dc50da-d6ec-45c9-9da6-2eff55c929ea |
| PRODUCT NDC: | 0591-2292 |
| APPLICATION NUMBER: | ANDA202808 |
Other DUTASTERIDE Pharmaceutical Manufacturers / Labelers:
